Chitharanjan Rao, MD
Neurology · Pompton Plains, NJNPI 1659306835
Payments from drug & device makers
Across 159 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$395
- AbbVie$350
- AstraZeneca$204
- Eisai Inc.$203
- Biogen$184
- UCB, Inc.$175
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,914100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $395 |
| AbbVie(2 entities) | 29 | $350 |
| AstraZeneca(2 entities) | 12 | $204 |
| Eisai Inc. | 8 | $203 |
| Biogen | 5 | $184 |
| UCB, Inc. | 8 | $175 |
| Bayer | 9 | $165 |
| Corcept Therapeutics | 8 | $146 |
| Pfizer | 7 | $121 |
| Xeris Pharmaceuticals, Inc. | 6 | $108 |
| Argenx US, Inc. | 4 | $75 |
| Abbott | 3 | $64 |
| Medtronic | 2 | $56 |
| Aucta Pharmaceuticals, Inc. | 4 | $55 |
| Radius Health, Inc. | 3 | $52 |
| GE HealthCare | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Novo Nordisk | 2 | $36 |
| Chiesi USA, Inc. | 1 | $33 |
| Johnson & Johnson | 2 | $31 |
| Novartis | 2 | $30 |
| Acadia Pharmaceuticals Inc | 2 | $30 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $27 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Catalyst Pharmaceuticals, Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $17 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
| Amgen | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Strongbridge US Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Cequr Corporation | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$104
How this compares
$2,914 in reported general payments places this provider in the 55th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 17 | $4,288 |
| Memantine Hcl | 60 | $1,664 |
| Gabapentin | 68 | $1,225 |
| Donepezil Hcl | 74 | $876 |
| Galantamine Hbr | 12 | $815 |
| Levetiracetam | 42 | $756 |
| Primidone | 12 | $664 |
| Divalproex Sodium ErDivalproex Sodium | 14 | $471 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 26 | $385 |
| Prednisone | 14 | $202 |
Paid to pharmacies, not to this prescriber.
Other neurology in Pompton Plains
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
- Andrew SylvesterBridgewater$1.1M
- Machteld HillenNewark$999K
- Matthew TremblayLivingston$812K
- Noah GilsonWest Long Branch$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.